Ong Sean W X, Daneman Nick, Davis Joshua S, Tong Steven Y C
Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Victorian Infectious Diseases Service, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Open Forum Infect Dis. 2025 Jan 30;12(2):ofaf063. doi: 10.1093/ofid/ofaf063. eCollection 2025 Feb.
Classification of patients with bacteremia as complicated versus uncomplicated is based on a combination of clinical and microbiologic variables. Whether daily body temperature and common laboratory tests such as C-reactive protein (CRP) and white blood cell (WBC) can improve risk stratification algorithms is unclear.
We conducted a post hoc secondary analysis of the CAMERA2 trial, which enrolled hospitalized adult patients with methicillin-resistant bacteremia and prospectively collected daily body temperature and peripheral blood WBC and CRP. We evaluated the prognostic relevance of each parameter by calculating crude and adjusted odds ratios for 90-day all-cause mortality comparing patients with the abnormal parameter of interest versus those with normal parameters on each day of illness.
A total of 345 patients were included in this analysis, of whom 63 (18.3%) died within 90 days. Fever (body temperature ≥38.0 °C) was associated with increased odds of 90-day mortality from day 4 and onwards. Fever later in the illness course was associated with higher adjusted odds of mortality (8.78; 95% confidence interval, 2.78-27.7 on day 7 vs adjusted odds ratio 3.70; 95% CI, 1.58-8.67 on day 4). In contrast, CRP and abnormal WBC count did not demonstrate a consistent or temporal association with mortality.
Persistent fever after 72 hours is associated with increased mortality in patients with methicillin-resistant bacteremia, supporting recommendations that this should be kept as a criterion for classifying patients as either "high-risk" or "complicated." Within this dataset, there was limited additional predictive value in WBC or CRP.
菌血症患者分为复杂性与非复杂性,这是基于临床和微生物学变量的综合判断。每日体温以及诸如C反应蛋白(CRP)和白细胞(WBC)等常见实验室检查能否改善风险分层算法尚不清楚。
我们对CAMERA2试验进行了事后二次分析,该试验纳入了住院的耐甲氧西林菌血症成年患者,并前瞻性收集了每日体温、外周血白细胞和CRP。我们通过计算疾病每一天有感兴趣的异常参数的患者与参数正常的患者90天全因死亡率的粗比值比和调整比值比,评估每个参数的预后相关性。
本分析共纳入345例患者,其中63例(18.3%)在90天内死亡。发热(体温≥38.0°C)从第4天及以后与90天死亡率增加相关。病程后期发热与更高的调整后死亡比值比相关(第7天为8.78;95%置信区间,2.78 - 27.7,而第4天调整后比值比为3.70;95% CI,1.58 - 8.67)。相比之下,CRP和白细胞计数异常与死亡率没有一致的或随时间变化的关联。
耐甲氧西林菌血症患者72小时后持续发热与死亡率增加相关,支持将此作为将患者分类为“高危”或“复杂性”的标准的建议。在该数据集中,白细胞或CRP的额外预测价值有限。